DTPA

EOB-DTPA is a biochemical reagent that can be synthesized from other compounds and is commonly used in MRI.

Calcium trinatrium diethylenetriaminepentaacetic acid hydrate (Ca-DTPA trisodium salt hydrate) is a metal chelator and a nontoxic inhibitor of CMV replication, as well as a useful antidote in cases of acute cadmium intoxication.

DTPA-tetra (t-Bu ester) is a bifunctional chelator (BFC) and a macrocyclic DPTA derivative used in tumor pre-targeting strategies. It is applicable for the conjugation of peptides and radionuclides.

18:0 PE-DTPA (Gd) diammonium is an MRI contrast agent.

Gadopentetic acid (gadolinium complex) (Gd-DTPA) is an paramagnetic contrast agent commonly implemented by a bolus intravenous injection (i.v.) in Dynamic contrast-enhanced MRI (DCE-MRI) studies.

Gadopentetate dimeglumine is used in magnetic resonance imaging (MRI) to allow blood vessels, organs and other non-bone tissues to be visualized more clearly.Gadopentetate dimeglumine induces atrophy of spermatogonia.

Gadoxetate Disodium is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging. It is a contrast agent in magnetic resonance imaging (MRI) of the hepatobiliary system. It accumulates in normal, fun

Pendetide, a chelating agent, is conjugable with Indium (111In) Capromab to create Capromab Pendetide, an FDA-approved imaging agent used for detecting soft tissue metastases in prostate carcinoma [1].

Barzuxetan is a potential research tool in oncology [1].

Barzuxetan (hydrochloride) is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DPTA derivative used for tumor pretargeting. It is suitable for conjugation with peptides and radionuclides.

Di-DTPA TL, a hydrophilic bivalent hapten derived from DTPA, is utilized in tumor research [1].

14:0 PE-DTPA (Gd) is a reagent used in biochemical reactions.

DTPA-BSA (Gd) can function as an MRI agent within lipid-like nanoparticles (LLN) designed for siRNA encapsulation.

Bz-DTPA (hydrochloride) is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DPTA derivative used for tumor pre-targeting. It is suitable for the conjugation of peptides and radionuclides.

p-NH2-CHX-A"-DTPA (hydrochloride hydrate) is a bifunctional chelator (Bifunctional Chelator; BFC) and macrocyclic DTPA derivative designed for tumor pre-targeting. It is suitable for conjugation with peptides and radionuclides.

Maleimido-mono-amide-DTPA (TFA) is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DPTA derivative employed in tumor pre-targeting. It is utilized for the conjugation of peptides and radionuclides.

p-NH₂-Bn-DTPA (hydrochloride) is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DPTA derivative used for tumor pre-targeting. It is suitable for the conjugation of peptides and radionuclides.

di-DTPA-LTL is a divalent hapten designed based on tyrosine-containing polypeptides. It exhibits excellent hydrophilicity and biodistribution properties. di-DTPA-LTL is labeled with 111In (indium) and 131I (iodine). By administering a fixed low dose (5 mg) of a bispecific antibody (anti-CEA x, anti-DTPA) and the di-DTPA hapten peptide (labeled with 111In) to patients, di-DTPA-LTL enables tumor radioimmunoimaging in patients with primary colorectal cancer expressing CEA.

18:0 PE-DTPA is a spin-labeled lipid that can interact with other membrane lipids.

16:0 PE-DTPA pentaammonium is a lipid that can interact with other membrane lipids.

16:0 PE-DTPA (Gd) is an MRI imaging agent.

14:0 PE-DTPA pentaammonium is both a phospholipid and a chelating agent.

Bis(14:0 PE)-DTPA (Gd) diammonium is an agent used in MRI imaging.

Super-chelating agent & MRI contrast agent